Clear Pharma Inc. – Trademark Portfolio

Entity Type: 03

Clear Pharma Inc. holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 10 filings in this category. The portfolio also extends into Class 38 (Telecommunications) across 5 Nice Classification classes. The owner is based in Westport, CT.

8 Wright Street

Westport, CT 06880

19 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Clear Pharma Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (10 filings)

Scientific and technological services; industrial analysis and research services

38
Telecommunications (6 filings)

Telecommunications

44
Medical Services (4 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

45
Legal & Security Services (1 filing)

Legal services; security services for the protection of property and individuals

Frequently Asked Questions

How many trademarks does Clear Pharma Inc. have?

Clear Pharma Inc. has 19 U.S. trademarks filed with the USPTO.

What trademark classes does Clear Pharma Inc. file in?

Clear Pharma Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 38 (Telecommunications), Class 44 (Medical Services), Class 35 (Advertising & Business), Class 45 (Legal & Security Services). Class 42 covers scientific and technological services; industrial analysis and research services.

What is Clear Pharma Inc.'s trademark registration success rate?

Clear Pharma Inc. has a 0% trademark registration rate, with 0 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.